ClearPoint Neuro Inc (CLPT) USD0.01

Sell:$11.50Buy:$14.00$0.62 (4.70%)

Prices delayed by at least 15 minutes
Sell:$11.50
Buy:$14.00
Change:$0.62 (4.70%)
Prices delayed by at least 15 minutes
Sell:$11.50
Buy:$14.00
Change:$0.62 (4.70%)
Prices delayed by at least 15 minutes

Company Information

About this company

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Key people

Joseph Michael Burnett
President, Chief Executive Officer, Director
Danilo D' Alessandro
Chief Financial Officer
Mazin Sabra
Chief Operating Officer
Jeremy L. Stigall
Chief Business Officer
R. John Fletcher
Independent Chairman of the Board
Lynnette C. Fallon
Independent Director
Pascal E.R. Girin
Independent Director
B. Kristine Johnson
Independent Director
Matthew B. Klein
Independent Director
Click to see more

Key facts

  • EPIC
    CLPT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US18507C1036
  • Market cap
    $347.06m
  • Employees
    115
  • Shares in issue
    27.63m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.